ArticleSurgery in practice and science2025
Simultaneous radical cystectomy and nephroureterectomy: A case series.
Article in Surgery in practice and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Simultaneous radical cystectomy and nephroureterectomy (RCNU) is a complex procedure. Although performed infrequently, RCNU may be indicated in certain cases of multifocal high grade urothelial carcinoma (UC) or muscle-invasive bladder cancer (MIBC) with an obstructed and atrophic kidney. The aim of this study was to review the indications, operative approach and outcomes for patients undergoing RCNU in our institution. Methods: A single-centre, retrospective review was performed. Cases were identified by reviewing theatre logbooks. Chart reviews were conducted and clinicopathological outcomes were recorded and analysed. Results: Eight patients were identified between 2015-2024. All were male and had a mean age of 66.4 ± 4.7 years. All patients underwent RCNU with ileal conduit formation. The surgical approach for the nephroureterectomy was laparoscopic in four cases and open in the remaining four. The mean post-operative length of stay was 11.6 ± 1.75 days. All patients had high grade UC, seven patients had MIBC at presentation. Only two patients received neoadjuvant chemotherapy, one of whom achieved a complete pathological response. In total, 62.5% (n=5) had T3/4 disease while 50% (n=4) had node positive disease. Two patients had synchronous upper tract urothelial carcinoma (UTUC) on final histology. The remaining cases had chronically obstructed and atrophic kidneys. Incidental primary prostate cancer was found in 62.5% (n=5). The mean follow-up was 31.6 ± 7 months, during which time there were four recurrences with three patients dying from metastatic disease. The mean overall survival was 21.8 ± 11.8 months and the mean disease-free survival was 19.3 ± 12.3 months. Conclusion: The results from this study demonstrate that combined laparoscopic and open RCNU is an effective treatment for both panurothelial cancer and MIBC with severe upper tract dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.